(Total Views: 587)
Posted On: 01/07/2021 2:28:01 PM
Post# of 148899
Will 25% reduction in deaths be the bar for EUA/approval in the UK? Expecting CD12 to crush it.
https://www.bbc.com/news/health-55574662
"In the REMAP-CAP trial carried out in six different countries, including the UK, with around 800 intensive care patients:
- Nearly 36% of intensive care Covid patients receiving standard care died
- The new drugs reduced that by a quarter, to 27%, when given to patients within 24 hours of them entering intensive care"
https://www.bbc.com/news/health-55574662
"In the REMAP-CAP trial carried out in six different countries, including the UK, with around 800 intensive care patients:
- Nearly 36% of intensive care Covid patients receiving standard care died
- The new drugs reduced that by a quarter, to 27%, when given to patients within 24 hours of them entering intensive care"
(1)
(0)Scroll down for more posts ▼
